Pfizer, Merck, Sanofi, GSK Will Continue to Dominate the Vaccine Market
The monopoly that Pfizer Inc., Merck & Co. Inc., Sanofi and GlaxoSmithKline plc (GSK) have on the vaccine market is unlikely to be broken, according to Jeffrey Holford, an equity analyst at global investment banking firm Jefferies. That market is projected to grow from $28.3 billion in 2015 to $72.5 billion in 2024. The four companies…
Global Vaccine Market Surging to More Than $70 Billion by 2024
Within the health care and pharmaceutical industry, the global vaccine market is one of the fastest growing segments and new predictions estimate the value of the market to reach between $48 billion and more than $70 billion over the next five to eight years. According to a new report released by Transparency Market Research, the value…
How Big Pharma Maintains Compliance, Brand Loyalty & Market Share
What can pharmaceutical companies do when their target audience cannot or will not comply with their prescribed medication recommendation? They target the caregiver, of course. For some patients, especially the mentally ill or the elderly, compliance is an issue. And Big Pharma does not want patients to miss a single dose of their medication. Compliance techniques are very…
World Vaccine Market Will Be Worth $77.5 Billion by 2024
A new market study by Grand View Research, Inc. of San Francisco, CA estimates the value of the world vaccine market at $32.5 billion in 2015. The study forecasts the market to grow to $77.5 billion by 2024. Grand View Research attributes the growth mainly to the “rising demand for better healthcare infrastructure and high awareness levels of the…
Study: World Vaccine Market Will Be Worth $45.1 Billion by 2022
A new market study by Kalorama Information, LLC of Rockville, MD estimates the value of the world vaccine market at $27.6 billion in 2015—up 11% from $24.7 billion in 2014 and 14% from $23.6 billion in 2013, reports Genetic Engineering Biotechnology News (GEN). According to the study, the market is projected to grow to $45.1 billion by 2022, owing to the continued…
The Vaccine Compensation Court
In the United States, if a person is harmed by a product, they have the right to seek compensation through the judicial system. This is not the case for those injured by vaccines. In the 1980’s, lawsuits against vaccine manufacturers and medical providers began to rise. Vaccine companies responded by claiming they would stop making vaccines because they were not making profits…